TACE联合氩氦刀冷冻治疗原发性肝癌临床分析  

Clinical analysis of primary hepatic carcinoma treated by TACE combined with cryoablation

作　　者：刘秋华[1] 周萃阶[1] 张伯[1] 蒋维[1] 李建伟[1] 

机构地区：[1]苏州大学附属张家港医院普外科,江苏苏州215600

出　　处：《肝胆胰外科杂志》2014年第4期278-280,共3页Journal of Hepatopancreatobiliary Surgery

摘　　要：目的探讨肝动脉化疗栓塞术(TACE)联合氩氦刀冷冻治疗原发性肝癌的近期疗效。方法将77例中晚期肝癌随机分为二组:A组37例,行TACE联合氩氦刀冷冻治疗;B组40例,单纯行TACE术。比较两组患者血清AFP水平以及半年和1年生存率。结果 A组AFP下降比B组明显(P<0.05),A组患者1年生存率高于B组(P<0.05)。结论 TACE联合氩氦刀冷冻治疗原发性肝癌疗效优于单纯性行TACE治疗,是治疗中晚期肝癌的一种有效方法。Objective To investigate the short-term curative effect in patients with primary hepatic carcinoma treated by TACE combined with cryoablation. Methods Seventy-seven cases of advanced hepatic carcinoma patients were randomized into group A （n=37）, treated by TACE combined with cryoablation, and patients in group B （n=40） treated with TACE alone. The level of AFP in serum, half and one year survival rate of patients were observed. Results The average level of AFP in group A was lower than that in group B significantly （P〈0.05）. One year survival rate of the patients in group A was higher than that in group B （P〈0.05）. Conclusion The treatment of TACE combined with cryoablation has more effective than TACE alone. TACE combined cryoablation is an effective method in treatment of advanced hepatic carcinoma.

关 键 词：氩氦冷冻治疗 肝动脉化疗栓塞术(TACE) 原发性肝癌 

分 类 号：R735.7[医药卫生—肿瘤]